Shenzhen Chipscreen Biosciences Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 348.59 million compared to CNY 335.67 million a year ago. Revenue was CNY 348.59 million compared to CNY 335.67 million a year ago.

Net income was CNY 108.08 million compared to net loss of CNY 42.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.2649 compared to basic loss per share from continuing operations of CNY 0.1037 a year ago. Diluted earnings per share from continuing operations was CNY 0.2649 compared to diluted loss per share from continuing operations of CNY 0.1037 a year ago.